Nearly 11.7 million people sign up for coverage through health insurance marketplace

As of Feb. 22, nearly 11.7 million people enrolled in the health insurance marketplace, including 8.84 million in states using the HealthCare.gov website, according to data from the Department of Health and Human Services.

Of the enrollees, more than 4.1 million were under the age of 35 and nearly 3.3 million were from 18 to 34 years of age.

The report did not include information on the number of people who paid their first month’s health plan premium.

In the 37 states that use Healthcare.gov, 87 percent of the people qualified for a tax credit, which averaged $263 per month. After accounting for the tax credits, 55 percent of people in those states paid $100 or less per month.

In addition, 53 percent of the enrollees in the states that use Healthcare.gov did not purchase coverage through the marketplace as of November 2014.

From March 15 to April 15, people in the 37 states using Healthcare.gov will be able to purchase insurance to avoid having to pay a penalty for not having coverage in 2015.

Read the report here.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.